Clinical trials: Hepatosplenic T-cell Lymphoma

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

• Recruiting
• Age: 18 years and older
• Phase 1
• Surgery or procedure

This phase I trial tests the safety, side effects and best dose of azacitidine in combination with belinostat and how well the combination works in treating patients with follicular helper T cell lymphoma (TFH) that has come back…

Conditions

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

Trial name

NCT07691450

Testing

Azacitidine, Belinostat, Biospecimen Collection

Where

2 sites in United States

Volunteers

40 people

Sponsor

City of Hope Medical Center